2026. 08. 26
New C2H Report: Tirzepatide (Zepbound)
New C2H Report: Donanemab (Kisunla)
2026. 06. 24
New C2H Report: Insulin Icodec (Awiqli)
View all news
2019. 03. 06
International symposium - Current status and future role of HTA in Japan and other countries
View all events